EA201590124A1 - Композиции и способы лечения или предупреждения пневмовирусной инфекции и связанных заболеваний - Google Patents

Композиции и способы лечения или предупреждения пневмовирусной инфекции и связанных заболеваний

Info

Publication number
EA201590124A1
EA201590124A1 EA201590124A EA201590124A EA201590124A1 EA 201590124 A1 EA201590124 A1 EA 201590124A1 EA 201590124 A EA201590124 A EA 201590124A EA 201590124 A EA201590124 A EA 201590124A EA 201590124 A1 EA201590124 A1 EA 201590124A1
Authority
EA
Eurasian Patent Office
Prior art keywords
methods
pneumatic
prevention
compositions
treatment
Prior art date
Application number
EA201590124A
Other languages
English (en)
Russian (ru)
Inventor
Роберт О. Кук
Юджин Р. Рейнолдз
Борис Шекунов
Сиеад И. Зегар
Original Assignee
Майкродоуз Терапьютикс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Майкродоуз Терапьютикс, Инк. filed Critical Майкродоуз Терапьютикс, Инк.
Publication of EA201590124A1 publication Critical patent/EA201590124A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EA201590124A 2012-06-29 2013-06-28 Композиции и способы лечения или предупреждения пневмовирусной инфекции и связанных заболеваний EA201590124A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261666258P 2012-06-29 2012-06-29
PCT/US2013/048723 WO2014005098A2 (en) 2012-06-29 2013-06-28 Compositions and methods for treating or preventing pneumovirus infection and associated diseases

Publications (1)

Publication Number Publication Date
EA201590124A1 true EA201590124A1 (ru) 2015-06-30

Family

ID=49778754

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201590124A EA201590124A1 (ru) 2012-06-29 2013-06-28 Композиции и способы лечения или предупреждения пневмовирусной инфекции и связанных заболеваний

Country Status (17)

Country Link
US (2) US9040569B2 (cg-RX-API-DMAC7.html)
EP (1) EP2867216A4 (cg-RX-API-DMAC7.html)
JP (1) JP2015524391A (cg-RX-API-DMAC7.html)
KR (1) KR20150037946A (cg-RX-API-DMAC7.html)
CN (1) CN104507918A (cg-RX-API-DMAC7.html)
AU (1) AU2013282286A1 (cg-RX-API-DMAC7.html)
BR (1) BR112014032290A2 (cg-RX-API-DMAC7.html)
CA (1) CA2877941A1 (cg-RX-API-DMAC7.html)
EA (1) EA201590124A1 (cg-RX-API-DMAC7.html)
HK (2) HK1210163A1 (cg-RX-API-DMAC7.html)
IL (1) IL236476A0 (cg-RX-API-DMAC7.html)
IN (1) IN2014DN10680A (cg-RX-API-DMAC7.html)
MX (1) MX2014015340A (cg-RX-API-DMAC7.html)
NZ (1) NZ628880A (cg-RX-API-DMAC7.html)
TW (1) TWI516283B (cg-RX-API-DMAC7.html)
WO (1) WO2014005098A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA201409073B (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201590124A1 (ru) 2012-06-29 2015-06-30 Майкродоуз Терапьютикс, Инк. Композиции и способы лечения или предупреждения пневмовирусной инфекции и связанных заболеваний
JP2017537958A (ja) * 2014-12-18 2017-12-21 メトリオファーム アーゲー 5−アミノ−2,3−ジヒドロフタラジン1,4−ジオンナトリウム塩の結晶形態、同一物を含む医薬製剤、及びこの形態の製造ための方法
KR20180105129A (ko) * 2015-11-30 2018-09-27 노부스 테라퓨틱스, 인크. 이과학적 예방 및 치료를 위한 조성물 및 방법
US10238821B2 (en) 2016-10-11 2019-03-26 Microdose Therapeutx, Inc. Inhaler and methods of use thereof
US20200085741A1 (en) * 2018-09-14 2020-03-19 Pharmosa Biopharm Inc. Pharmaceutical composition for controlled release of weak acid drugs and uses thereof
CN109827875A (zh) * 2019-04-10 2019-05-31 上海市食品药品检验所 一种用于测定吸入制剂溶出度的装置和方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6495580B1 (en) 1998-01-29 2002-12-17 Viropharma Incorporated Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
CN1289248A (zh) * 1998-01-29 2001-03-28 维洛药品公司 治疗或预防肺病毒感染及有关疾病的化合物、组合物和方法
WO2002059132A1 (en) 2001-01-26 2002-08-01 Viropharma Incorporated Intermediate compounds useful for making antiviral compounds
US8202896B2 (en) 2002-08-09 2012-06-19 Microdose Therapeutx, Inc. Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
EP1539691A2 (en) 2002-08-09 2005-06-15 Viropharma Incorporated Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
EA201590124A1 (ru) 2012-06-29 2015-06-30 Майкродоуз Терапьютикс, Инк. Композиции и способы лечения или предупреждения пневмовирусной инфекции и связанных заболеваний

Also Published As

Publication number Publication date
NZ628880A (en) 2016-08-26
HK1210163A1 (en) 2016-04-15
BR112014032290A2 (pt) 2017-06-27
EP2867216A2 (en) 2015-05-06
US9504672B2 (en) 2016-11-29
US9040569B2 (en) 2015-05-26
TW201416093A (zh) 2014-05-01
US20140005239A1 (en) 2014-01-02
CA2877941A1 (en) 2014-01-03
ZA201409073B (en) 2016-08-31
CN104507918A (zh) 2015-04-08
KR20150037946A (ko) 2015-04-08
US20150209328A1 (en) 2015-07-30
IL236476A0 (en) 2015-02-26
TWI516283B (zh) 2016-01-11
AU2013282286A1 (en) 2015-01-22
WO2014005098A2 (en) 2014-01-03
MX2014015340A (es) 2015-03-05
IN2014DN10680A (cg-RX-API-DMAC7.html) 2015-08-28
WO2014005098A3 (en) 2014-02-27
JP2015524391A (ja) 2015-08-24
EP2867216A4 (en) 2015-12-09
HK1203956A1 (en) 2015-11-06

Similar Documents

Publication Publication Date Title
EA201491028A1 (ru) Способ получения замещенных 5-фтор-1н-пиразолопиридинов
EA201301320A1 (ru) 4-арил-n-фенил-1,3,5-триазин-2-амины, которые содержат сульфоксиминную группу
EA201391719A1 (ru) Хиназолиновые производные для лечения вирусных инфекций и дальнейших заболеваний
MY183534A (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diseases
EA201300604A1 (ru) Соединения, предназначенные для лечения респираторно-синцитиальных вирусных инфекций
MD4496B1 (ro) Analogi carba-nucleozidici 2'-substituiţi pentru tratament antiviral
IN2014DN09173A (cg-RX-API-DMAC7.html)
IL230458A0 (en) Compounds for the treatment and prevention of respiratory syncytial viral disease
AU2011286276A8 (en) Substituted Biphenylene Compounds and methods of use thereof for the treatment of viral diseases
EA201590667A1 (ru) Ациламинопиримидиновые производные для лечения вирусных инфекций и других заболеваний
WO2012173682A3 (en) Compounds and methods for the treatment of isocitrate dehydrognase related diseases
MX2014003169A (es) Ligandos del receptor ep1.
MX2013012233A (es) 4-aril-n-fenil-1,3,5-triazin-2-aminas sustituidas.
HK1211290A1 (en) Heterocycle-substitued tetracyclic compounds and methods of use thereof for treatment of viral diseases
EA201170356A1 (ru) Полиморфные и аморфные формы лакозамида и аморфные композиции
EA201400623A1 (ru) Новые 2h-индазолы в качестве антагонистов рецептора ep
MX2014015340A (es) Composiciones y metodos para tratar o evitar infeccion por pneumovirus y enfermedades asociadas.
TW201129572A (en) Compounds for treating respiratory syncytial virus infections
IN2013DN02555A (cg-RX-API-DMAC7.html)
PH12014501943A1 (en) Novel compounds for the treatment of dyslipidemia and related diseases
EP2792666A4 (en) PHORBOL DITERPEN COMPOUND, PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF VIRAL INFECTION DISEASES THEREWITH
EA019080B9 (ru) α-КРИСТАЛЛИЧЕСКАЯ ФОРМА КАРБАБЕНЗПИРИДА
IN2014DN10683A (cg-RX-API-DMAC7.html)
ZA201400442B (en) Compounds for the treatment and prophylaxis of respiratory syncytial virus disease